LOINC
Version 2.73

6822-1Nuclear Ab [Titer] in Synovial fluid by ImmunofluorescenceActive

Part Descriptions

LP16670-9   Nuclear
The nucleus of a cell contains the body's genetic material. It is the site of transcriptional regulation, RNA processing and DNA synthesis and transcription.
[PMID:24563360] Source: Regenstrief LOINC

LP20752-9   Nuclear Ab
Anti-nuclear antibodies (ANAs), also known as anti-nuclear factor or ANF, are auto-antibodies directed against contents of the cell nucleus. They are present in low numbers in the general population but higher than normal amounts in autoimmune diseases, including lupus erythematosus, Sjogren's syndrome, rheumatoid arthritis, scleroderma, and autoimmune hepatitis. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Anti-nuclear antibodies

LP20752-9   Nuclear Ab
Anti-nuclear antibodies (ANAs, also known as anti-nuclear factor or ANF) are autoantibodies directed against contents of the cell nucleus. They are present in higher than normal numbers in autoimmune disease. The ANA test measures the pattern and amount of autoantibody which can attack the body's tissues as if they were foreign material. Autoantibodies are present in low titers in the general population, but in about 5% of the population, their concentration is increased, and about half of this 5% have an autoimmune disease.

The presence of ANA is indicative of lupus erythematosus (present in 80-90% of cases), though they also appear in some other auto-immune diseases such as[citation needed] Sjögren's syndrome (60%), rheumatoid arthritis (30-40%), autoimmune hepatitis, scleroderma and polymyositis & dermatomyositis (30%), and various non-rheumatological conditions associated with tissue damage. Other conditions with high ANA titre include Addison disease, Idiopathic thrombocytopenic purpura (ITP), Hashimoto's, Autoimmune hemolytic anemia, Type I diabetes mellitus, Mixed connective tissue disorder. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia

Fully-Specified Name

Component
Nuclear Ab
Property
Titr
Time
Pt
System
Synv fld
Scale
Qn
Method
IF

Additional Names

Short Name
ANA Titr Snv IF
Display Name
Nuclear Ab IF (Syn fld) [Titer]
Consumer Name Alpha
Nuclear antibody, Synovial fluid

Basic Attributes

Class
SERO
Type
Laboratory
First Released
Version 1.0h(2)
Last Updated
Version 2.73
Order vs. Observation
Both
Common US Lab Results Rank
17480

Member of these Groups

LG2801-1 Nuclear Ab|Titr|Pt|Synv fld

Language Variants Get Info

zh-CNChinese (China)
细胞核 抗体:滴定度:时间点:滑液:定量型:免疫荧光法
nl-NLDutch (Netherlands)
nucleaire As:titer:moment:synoviaal vocht:kwantitatief:immunofluorescentie
et-EEEstonian (Estonia)
Tuumavastased antikehad:Titr:Pt:SynF:Qn:IF
fr-BEFrench (Belgium)
Nucléaire Ac:Titre:Temps ponctuel:Liquide synovial:Quantitatif:Immunofluorescence
fr-CAFrench (Canada)
Nucléaire , Ac:Titre:Temps ponctuel:Liquide synovial:Quantitatif:Immunofluorescence
fr-FRFrench (France)
Noyau anticorps:Titre:Ponctuel:Liquide synovial:Numérique:Immunofluorescence
it-ITItalian (Italy)
Nucleare Ab:Titr:Pt:Liquido sinoviale:Qn:IF
ko-KRKorean (Korea, Republic of)
핵 항체:역가:검사시점:활액:정량:면역 형광 측정법
pt-BRPortuguese (Brazil)
Nuclear Ac:Título:Pt:LiqSinov:Qn:Anticorpo fluorescente indireto
ru-RURussian (Russian Federation)
Ядерный Ат:Титр:ТчкВрм:Синов ждк:Колич:ИФ
es-ARSpanish (Argentina)
anticuerpo inmunofluerescente:factor de dilución (titulación):punto en el tiempo:líquido sinovial:cuantitativo:IFA
es-MXSpanish (Mexico)
Ab nuclear:Título:Punto temporal:Líquido sinovial:Cuantitativo:Inmunofluorescencia (IF)
es-ESSpanish (Spain)
Nuclear Anticuerpos:Titulo / Factor de dilución:Punto temporal:Líquido sinovial:Qn:Inmunofluorescencia (IF)
tr-TRTurkish (Turkey)
Nükleer Ab:Titr:Zmlı:Snvy sv:Kant:IF

Example Units

Unit Source
{titer} Example UCUM Units

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=6822-1